| Assay ID | Title | Year | Journal | Article |
|---|
| AID354885 | Inhibition of arachidonic acid-induced platelet aggregation in rabbit platelet-rich plasma at 100 ug/ml by turbidimetric method | 1996 | Journal of natural products, May, Volume: 59, Issue:5
| Antiplatelet of vasorelaxing actions of some benzylisoquinoline and phenanthrene alkaloids. |
| AID354888 | Inhibition of collagen-induced platelet aggregation in rabbit platelet-rich plasma at 100 ug/ml by turbidimetric method | 1996 | Journal of natural products, May, Volume: 59, Issue:5
| Antiplatelet of vasorelaxing actions of some benzylisoquinoline and phenanthrene alkaloids. |
| AID354882 | Inhibition of adenosine diphosphate-induced platelet aggregation in rabbit platelet-rich plasma at 100 ug/ml by turbidimetric method | 1996 | Journal of natural products, May, Volume: 59, Issue:5
| Antiplatelet of vasorelaxing actions of some benzylisoquinoline and phenanthrene alkaloids. |
| AID354891 | Inhibition of platelet-activity factor-induced platelet aggregation in rabbit platelet-rich plasma at 100 ug/ml by turbidimetric method | 1996 | Journal of natural products, May, Volume: 59, Issue:5
| Antiplatelet of vasorelaxing actions of some benzylisoquinoline and phenanthrene alkaloids. |
| AID354902 | Vasorelaxant activity against norepinephrine-induced tonic contraction in Wistar rat thoracic aorta at 100 ug/ml | 1996 | Journal of natural products, May, Volume: 59, Issue:5
| Antiplatelet of vasorelaxing actions of some benzylisoquinoline and phenanthrene alkaloids. |
| AID356082 | Displacement of [3H]diltiazem from benzodiazepine binding site of L-type calcium channel in Wistar rat cerebral cortex membrane | 2003 | Journal of natural products, Jul, Volume: 66, Issue:7
| Simplified tetrandrine congeners as possible antihypertensive agents with a dual mechanism of action. |
| AID356083 | Vasorelaxant activity against noradrenaline-induced contraction in Wistar rat thoracic aorta in presence of calcium | 2003 | Journal of natural products, Jul, Volume: 66, Issue:7
| Simplified tetrandrine congeners as possible antihypertensive agents with a dual mechanism of action. |
| AID356081 | Displacement of [3H]prazosin from alpha1 adrenergic receptor in Wistar rat cerebral cortex membrane | 2003 | Journal of natural products, Jul, Volume: 66, Issue:7
| Simplified tetrandrine congeners as possible antihypertensive agents with a dual mechanism of action. |
| AID356085 | Vasorelaxant activity against KCl-induced contraction in Wistar rat thoracic aorta at 100 uM in presence of calcium | 2003 | Journal of natural products, Jul, Volume: 66, Issue:7
| Simplified tetrandrine congeners as possible antihypertensive agents with a dual mechanism of action. |
| AID354894 | Vasorelaxant activity against high potassium-induced contraction in Wistar rat thoracic aorta at 100 ug/ml | 1996 | Journal of natural products, May, Volume: 59, Issue:5
| Antiplatelet of vasorelaxing actions of some benzylisoquinoline and phenanthrene alkaloids. |
| AID354898 | Vasorelaxant activity against norepinephrine-induced phasic contraction in Wistar rat thoracic aorta at 100 ug/ml | 1996 | Journal of natural products, May, Volume: 59, Issue:5
| Antiplatelet of vasorelaxing actions of some benzylisoquinoline and phenanthrene alkaloids. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID1347083 | qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen | 2020 | Antiviral research, 01, Volume: 173 | A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity. |
| AID1347082 | qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal | 2020 | Antiviral research, 01, Volume: 173 | A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID1347086 | qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal | 2020 | Antiviral research, 01, Volume: 173 | A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity. |
| AID504812 | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7
| A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
| AID504810 | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7
| A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
| AID1745845 | Primary qHTS for Inhibitors of ATXN expression | | | |
| AID651635 | Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression | | | |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |